Overall, results with primary tumors demonstrated a significant concordance with our in vitro results where cancer cell proliferation and frequency of oral-SLCCs were significantly varying depending on the levels of myofibroblastic-αSMA-positive CAFs in gingivobuccal oral carcinoma. The gene discussed is ACTA1; the disease is cancer.